• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
HU Shihao, YU Xinyue, LI Ruiting, WU Xiaoxia, YANG Xuping, HAN Zhaodi, HUANG Yin. Analysis of the differential compounds in Astragalus membranaceus from different geographical origins by UFLC-IT-TOF/MS[J]. Journal of China Pharmaceutical University, 2019, 50(1): 59-65. DOI: 10.11665/j.issn.1000-5048.20190108
Citation: HU Shihao, YU Xinyue, LI Ruiting, WU Xiaoxia, YANG Xuping, HAN Zhaodi, HUANG Yin. Analysis of the differential compounds in Astragalus membranaceus from different geographical origins by UFLC-IT-TOF/MS[J]. Journal of China Pharmaceutical University, 2019, 50(1): 59-65. DOI: 10.11665/j.issn.1000-5048.20190108
shu

Analysis of the differential compounds in Astragalus membranaceus from different geographical origins by UFLC-IT-TOF/MS

More Information
    Graphical Abstract
    • Abstract
  • To uncover the differences in material basis of Astragalus membranaceus from different origins, ultra-fast liquid chromatography-ion trap time-of-flight mass spectrometry(UFLC-IT-TOF/MS)was applied to characterize chemical features of 15 batches of water decoction of Astragalus membranaceus from Gansu Province and Inner Mongolia Autonomous Region. Pattern recognition and statistical analysis were performed using partial least squares-discriminant analysis(PLS-DA)and(non)parametric tests, respectively. The differential compounds with variable importance in projection(VIP)> 1, adjusted P< 0. 05, and fold change(FC)> 1. 5 were screened out and further identified. It was found that 7 different substances such as calycosin, formononetin and linoleic acid could be used as quality markers to distinguish the origin of Astragalus membranaceus. Our findings provided new potential quality markers for the accurate differentiation of geographical origins of Astragalus membranaceus as well as its comprehensive quality control.
    • FullText(HTML)
    • References (23)
  • [1]
    Chinese Pharmacopoeia Committee.Pharmacopoeia of the People′s Republic of China:part 1(中华人民共和国药典:一部)[S].Beijing:China Medical Science Press,2015:302-303.
    [2]
    Fu J,Wang Z,Huang L,et al.Review of the botanical characteristics,phytochemistry,and pharmacology of Astragalus membranaceus(Huangqi)[J].Phytother Res,2014,28(9):1275-1283.
    [3]
    Jin M,Zhao K,Huang Q,et al.Structural features and biological activities of the polysaccharides from Astragalus membranaceus[J].Int J Biol Macromol,2014,64:257-266.
    [4]
    Li M,Wang W,Xue J,et al.Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy[J].J Ethnopharmacol,2011,133(2):412-419.
    [5]
    Jiao J,Gai QY,Niu LL,et al.Enhanced production of two bioactive isoflavone aglycones in Astragalus membranaceus hairy root cultures by combining deglycosylation and elicitation of immobilized edible Aspergillus niger [J].J Agric Food Chem,2017,65(41):9078-9086.
    [6]
    Shahzad M,Shabbir A,Wojcikowski K,et al.The antioxidant effects of Radix Astragali(Astragalus membranaceus and related species)in protecting tissues from injury and disease[J].Curr Drug Tar,2016,17(12):1331-1340.
    [7]
    Liao XF,Bi XL,Xu AL,et al.Fingerprint and three constituents′ quantitative determination for Astragali Radix from different regions by HPLC-DAD-ELSD[J].J Guangdong Pharm Univ(广东药科大学学报),2018,34(5):558-563.
    [8]
    Tian D,Li ZY,Fan SC,et al.NMR-based analysis of water soluble extracts of different Astragali Radix[J].Acta Pharm Sin(药学学报),2014,49(1):89-94.
    [9]
    He JX,Mou QQ,Zhang JQ,et al.Rapid identification of Astragali Radix from different origins by UPLC combined with chemometrics methods [J].Chin Tradit Herbal Drugs(中草药),2017,48(1):179-184.
    [10]
    Lai PK,Chan JY,Cheng L,et al.Isolation of anti-inflammatory fractions and compounds from the root of Astragalus membranaceus[J].Phytother Res,2013,27(4):581-587.
    [11]
    Li J, Li F, Xu Y, et al. Chemical composition and synergistic antioxidant activities of essential oils from Atractylodes macrocephala and Astragalus membranaceus[J].Nat Prod Commun,2013,8(9):1321-1324.
    [12]
    Guan QX, Li CD. Screening test study on seedling pattern of Astragalus membranaceus in different climate regions of Longxi(陇西不同气候区域黄芪育苗模式筛选试验研究)[J].J Chin Med Mate(中药材),2016,39(3):490-492.
    [13]
    Liu DW,Gu CM,Yang QZ,et al.Resource surveys and suitability of origin for genuine medicinal materials,Astragalus membranaceus var.mongholicus in Inner Mongolia,China[J].Chin J Appl Ecol(应用生态学报),2016,27(3):838-844.
    [14]
    Kai Z,Michela P,Antonio P and Annamaria P.Biological active ingredients of traditional Chinese herb Astragalus membranaceus on treatment of diabetes:a systematic review[J].Mini-Rev Med Chem,2015,15(4):315-329.
    [15]
    Zhang LJ,Liu HK,Hsiao PC,et al.New isoflavonoid glycosides and related constituents from astragali radix(Astragalus membranaceus)and their inhibitory activity on nitric oxide production[J].J Agric Food Chem,2011,59(4):1131-1137.
    [16]
    Nie Y,Li S,Yi Y,et al.Effects of astragalus injection on the TGFβ/Smad pathway in the kidney in type 2 diabetic mice[J].BMC Complem Altern Med,2014,14(1):148.
    [17]
    Li W,Sun YN,Yan XT,et al.Flavonoids from Astragalus membranaceus and their inhibitory effects on LPS-stimulated pro-inflammatory cytokine production in bone marrow-derived dendritic cells[J].Arch Pharm Res,2014,37(2):186-192.
    [18]
    Zhou R,Xu L,Ye M,et al.Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways[J].Horm Metab Res,2014,46(11):753-760.
    [19]
    Capozzi V,Menga V,Digesu AM,et al.Biotechnological production of vitamin B2-enriched bread and pasta[J].J Agric Food Chem,2011,59(14):8013-8020.
    [20]
    Yang B,Chen H,Stanton C,et al.Review of the roles of conjugated linoleic acid in health and disease[J].J Funct Foods,2015,15:314-325.
    [21]
    Villacorta L,Minarrieta L,Salvatore SR,et al.In situ generation,metabolism and immunomodulatory signaling actions of nitro-conjugated linoleic acid in a murine model of inflammation[J].Redox Bio,2018,15:522-531.
    [22]
    Wang Y,Fan X,Qu H,et al.Strategies and techniques for multi-component drug design from medicinal herbs and traditional Chinese medicine[J].Curr Top Med Chem,2012,12(12):1356-1362.
    [23]
    Fu S,Gu Y,Jiang JQ,et al.Calycosin-7-O-β-d-glucoside regulates nitric oxide/caveolin-1/matrix metalloproteinases pathway and protects blood-brain barrier integrity in experimental cerebral ischemia-reperfusion injury[J].J Ethnopharmacol,2014,155(1):692-701.
    • Related Articles

  • Related Articles

    [1]YE Zhenning, WU Zhenghong, ZHANG Huaqing. Research progress of blood-brain barrier crossing strategies and brain-targeted drug delivery mediated by nano-delivery system[J]. Journal of China Pharmaceutical University, 2024, 55(5): 590-602. DOI: 10.11665/j.issn.1000-5048.2024052202
    [2]LUO Xuelian, WU Chengsheng, ZHA Cheng, LIU Sheng. Research progress and prospects of implantable drug delivery systems for postoperative tumor therapy[J]. Journal of China Pharmaceutical University, 2024, 55(4): 538-547. DOI: 10.11665/j.issn.1000-5048.2024040901
    [3]WANG Shihao, LIU Lifeng, DING Yang, LI Suxin. Research progress of pH-responsive drug delivery systems in cancer immunotherapy[J]. Journal of China Pharmaceutical University, 2024, 55(4): 522-529. DOI: 10.11665/j.issn.1000-5048.2024011902
    [4]YU Jiayu, LIN Zezhi, CAO Wei, ZHANG Jianjun, WEI Yuanfeng, GAO Yuan, QIAN Shuai. Research progress of bio-metal organic frameworks in drug delivery system[J]. Journal of China Pharmaceutical University, 2023, 54(1): 23-33. DOI: 10.11665/j.issn.1000-5048.20221111003
    [5]ZHOU Yeshu, WANG Yanmei, ZHANG Beiyuan, WU Shuaicong, YANG Lei, YIN Lifang. Research progress of inorganic nanomaterials in drug delivery system[J]. Journal of China Pharmaceutical University, 2020, 51(4): 394-405. DOI: 10.11665/j.issn.1000-5048.20200403
    [6]LI Haoxian, LIN Huaqing, CHEN Jingwen, WANG Liyuan. Research progress of carbon nanomaterials in cancer drug delivery[J]. Journal of China Pharmaceutical University, 2019, 50(1): 100-106. DOI: 10.11665/j.issn.1000-5048.20190114
    [7]FAN Qianqian, XING Lei, QIAO Jianbin, ZHANG Chenglu, JIANG Hulin. Advances in drug delivery systems for the treatment of liver fibrosis[J]. Journal of China Pharmaceutical University, 2018, 49(3): 263-271. DOI: 10.11665/j.issn.1000-5048.20180302
    [8]CHEN Xing, KANG Yang, WU Jun. Advances in biodegradable functional polymers based protein drug delivery system[J]. Journal of China Pharmaceutical University, 2017, 48(2): 142-149. DOI: 10.11665/j.issn.1000-5048.20170203
    [9]WANG Yazhe, ZHOU Jianping, DING Yang, WANG Wei. Advances in research of biomimetic drug delivery systems[J]. Journal of China Pharmaceutical University, 2014, 45(3): 267-273. DOI: 10.11665/j.issn.1000-5048.20140303
    [10]TANG Yue, KE Xue. Advances of mesoporous silica nanoparticles as drug delivery system[J]. Journal of China Pharmaceutical University, 2012, 43(6): 567-572.

  • Cited by

    Periodical cited type(0)

    Other cited types(2)

Catalog

    Get Citation
    PDF
    XML
    Article views (956) PDF downloads (1205) Cited by(2)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：286205

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return